Tracked deals
4
4 tracked deals across 2019-2023.
Operating Company
Manufacturing
Sterling Pharma Solutions
Dudley, Northumberland, United Kingdom
Global contract development and manufacturing organisation (CDMO) specialising in small-molecule API development and manufacturing and ADC development/manufacturing and bioconjugation (via a “PDMO®” model).
- Focus Areas
- Contract development and manufacturing (CDMO), Small-molecule API development and manufacturing, ADC development and bioconjugation
- Website
- www.sterlingpharmasolutions.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
4 addon
Sterling Pharma Solutions Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
- Buyer
- Sterling Pharma Solutions, GHO Capital Partners LLP
- Target
- Novartis Ringaskiddy facility (Novartis Ringaskiddy Limited)
- Seller
- Novartis
- Industry
- Pharmaceuticals
- Location
- County Cork, Ireland
- Type
- Addon
Sterling Pharma Solutions, a GHO Capital portfolio company, has completed the acquisition of the Novartis API manufacturing facility in Ringaskiddy, County Cork, Ireland. The 111-acre site (with ~350 transferred employees and extensive commercial-scale API production capacity) expands Sterling's European manufacturing footprint and includes an ongoing supply agreement with Novartis.
-
April 7, 2021
- Buyer
- Sterling Pharma Solutions, GHO Capital Partners LLP
- Target
- ADC Biotechnology
- Industry
- Biotechnology
- Location
- Wales, United Kingdom
- Type
- Addon
Sterling Pharma Solutions, a GHO Capital portfolio CDMO, has acquired ADC Biotechnology (ADC Bio), a Deeside-based bioconjugation and ADC development services business. The deal adds ADC capabilities and a Deeside facility to Sterling’s international network and includes multi-million pound investment to grow bioconjugation, analytical and cGMP ADC manufacturing capabilities.
-
- Buyer
- Sterling Pharma Solutions, GHO Capital Partners LLP
- Target
- Alcami Germantown facility
- Seller
- Alcami
- Industry
- Pharmaceuticals
- Location
- Wisconsin, United States
- Type
- Addon
Sterling Pharma Solutions, a portfolio company of GHO Capital Partners, has acquired Alcami’s Germantown, Wisconsin API development and manufacturing facility. The facility expands Sterling’s US footprint and adds cGMP capacity for complex and hazardous API projects, including plant-scale hydrogenation and cryogenic reactions.
-
- Buyer
- Sterling Pharma Solutions
- Target
- CiVentiChem (US facility)
- Seller
- CiVentiChem
- Industry
- Pharmaceuticals
- Location
- North Carolina, United States
- Type
- Addon
UK-based CDMO Sterling Pharma Solutions, a portfolio company of GHO Capital, has acquired the CiVentiChem US facility in Cary, North Carolina to establish a local presence for its North American clients and expand its chemistry development and kilo-scale cGMP capabilities. The acquisition supports Sterling’s strategy to build a global chemistry services business and follows GHO Capital’s majority investment in Sterling earlier this year.
Related Acquisition Pages
Pharmaceuticals Buyers & Acquisitions
3 tracked deals by Sterling Pharma Solutions.
Biotechnology Buyers & Acquisitions
1 tracked deal by Sterling Pharma Solutions.
Acquisitions in North Carolina
1 tracked deal by Sterling Pharma Solutions.
Acquisitions in Wisconsin
1 tracked deal by Sterling Pharma Solutions.
Selling a company? Get in front of buyers like Sterling Pharma Solutions
Turn tracked acquisition activity into an outreach-ready buyer list.